H M Chapel|J R Batchelor - JoVE Visualize

Showing results (41-50 of 154) with videos related to

Pageof 16

Sort By:

Journal of Immunological Methods|August 30, 1992

A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiencyJ A Faux, A E Agbarakwe, S A Misbah, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998

TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous diseaseC G Mullighan, G C Fanning, H M Chapel, et al.

Annals of the Rheumatic Diseases|April 1, 1981

Lymphocytotoxins in rheumatoid arthritis: prevalence, lymphocyte specificity, and HLA-DR antigensP H Wooley, G S Panayi, J R Batchelor

Immunology|August 1, 1979

An immunogenetic basis for the tissue involvement in Behçet's syndromeT Lehner, J R Batchelor, S J Challacombe, et al.

Transplantation|January 1, 1993

Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitizationM Y Braun, A McCormack, G Webb, et al.

International Immunology|August 1, 1992

Structural analysis of human anti-mouse H-2E xenorecognition: T cell receptor bias and impaired CD4 interaction contribute to weak xenoresponsesP Ramesh, L Barber, J R Batchelor, et al.

Transplantation|May 1, 1987

Analysis of the alloreactive T cell repertoire in man. I. Differences in precursor frequency for cytotoxic T cell responses against allogeneic MHC molecules in unrelated individualsC E Sharrock, S Man, W Wanachiwanawin, et al.

Lancet (London, England)|April 30, 1994

Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple MyelomaH M Chapel, M Lee, R Hargreaves, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989

Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptidesG Lombardi, S Sidhu, J R Batchelor, et al.

The Journal of Experimental Medicine|September 19, 1979

Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipientsJ R Batchelor, K I Welsh, A Maynard, et al.

Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:

Pageof 16

Journal of Immunological Methods|August 30, 1992

A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiencyJ A Faux, A E Agbarakwe, S A Misbah, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998

TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous diseaseC G Mullighan, G C Fanning, H M Chapel, et al.

Annals of the Rheumatic Diseases|April 1, 1981

Lymphocytotoxins in rheumatoid arthritis: prevalence, lymphocyte specificity, and HLA-DR antigensP H Wooley, G S Panayi, J R Batchelor

Immunology|August 1, 1979

An immunogenetic basis for the tissue involvement in Behçet's syndromeT Lehner, J R Batchelor, S J Challacombe, et al.

Transplantation|January 1, 1993

Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitizationM Y Braun, A McCormack, G Webb, et al.

International Immunology|August 1, 1992

Structural analysis of human anti-mouse H-2E xenorecognition: T cell receptor bias and impaired CD4 interaction contribute to weak xenoresponsesP Ramesh, L Barber, J R Batchelor, et al.

Transplantation|May 1, 1987

Analysis of the alloreactive T cell repertoire in man. I. Differences in precursor frequency for cytotoxic T cell responses against allogeneic MHC molecules in unrelated individualsC E Sharrock, S Man, W Wanachiwanawin, et al.

Lancet (London, England)|April 30, 1994

Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple MyelomaH M Chapel, M Lee, R Hargreaves, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989

Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptidesG Lombardi, S Sidhu, J R Batchelor, et al.

The Journal of Experimental Medicine|September 19, 1979

Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipientsJ R Batchelor, K I Welsh, A Maynard, et al.

Pageof 16